The Role of Methylene Blue in the Pediatric Patient With Vasoplegic Syndrome

World Journal for Pediatric and Congenital Heart Surgery

Volumn 2, Issue 4, 2011, Pages 652-655

  Bhalla, Tarun ^a   Sawardekar, Amod ^a   Russell, Hyde ^b   Tobias, Joseph D ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

anesthesia (includes agents; care and research); congenital heart surgery; heart; organ or cell); pharmacology; pharmacology (combine with target disease; transplantation; vascular tone and reactivity

Indexed keywords

EID: 84992884520     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135111410992     Document Type: Article

References (19)

1. Gomes WJ Carvalho AC Palma JH Gonçalves I Jr Buffolo E. Vasoplegic syndrome: a new dilemma. J Thorac Cardiovasc Surg. 1994; 107(3):942–943.
2. Shanmugam G. Vasoplegic syndrome–the role of methylene blue. Eur J Cardiothorac Surg. 2005; 28(5):705–710.
3. Andrade JCS Batista Filho ML Evora PRB, et al. Methylene blue administration in the treatment of the vasoplegic syndrome after cardiac surgery. Rev Bras Cir Cardiovasc. 1996; 11: 107–114.
4. Leyh RG Kofidis T Struber M, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2003; 125(6):1426–1431.
5. Driscoll W Thurin S Carrion V Steinhorn RH Morin FC 3rd. Effect of methylene blue on refractory neonatal hypotension. J Pediatr. 1996; 129(6):904–907.
6. Taylor K Holtby H. Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis. J Thor Cardiovasc Surg. 2005; 130(2):566.
7. Flynn BC Sladen RN. The use of methylene blue for vasodilatory shock in a pediatric lung transplant patient. J Cardiothor Vasc Anesth. 2009; 23(4):529–530.
8. Dagenais F Mathieu P. Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery. Can J Cardiol. 2003; 19(2):167–169.
9. Shi Y Li H-Q Shen C-K, et al. Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr. 1993; 123(3):435–438.
10. Moncada S Palmer R Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43(2):109–142.
11. Kilbourn R Gross S Jubran A, et al. N-g-methyl-l-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A. 1990; 87(9):3629–3632.
12. Kofidis T Struber M Wilhelmi M, et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg. 2001; 122(4):823–824.
13. Pagni S Austin EH. Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2000; 119(6):1297–1298.
14. Yiu P Robin J Pattison CW. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 1999; 118(1):195–196.
15. Gachot B Bedos JP Veber B Wolff M Regnier B. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med. 1995; 21(12):1027–1031.
16. Kirov MY Evegnov OV Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001; 29(10):1860–1867.
17. Evora PRB Rodrigues AJ. Methylene blue revised. J Thorac Cardiovasc Surg. 2006; 131(1):250–251.
18. Levin RL Degrange MA Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004; 77(2):496–499.
19. Ozal E Kuralay E Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005; 79(5):1615–1619.